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1. Introduction  
The temporal pole (TP), located in the anterior tip of the temporal lobe, is a 
component of the paralimbic circuit along with the orbitofrontal cortex and the 
insular cortex (Mesulam and Mufson, 1982). The TP has been considered to be 
engaged in various cognitive functions and has been thought to play a role in 
affectional–sensory integration (Nakamura and Kubota, 1996; Gloor, 1997; 
Mesulam, 2000). Neuroimaging investigations have shown that the pathological  
process in schizophrenia predominantly affects the fronto–temporolimbic–  
paralimbic regions (Takahashi et al., 2009). Nonetheless, neuroimaging studies of 
the TP in schizophrenia patients have shown inconsistent results. Kasai et al. 
(2003), using a region of interest (ROI) approach, reported a significant graymatter 
volume reduction in the left TP in first-episode schizophrenia patients. 
Inconsistently,Witthaus et al. (2009), using voxel-based morphometry 
methodology, reported a significant reduction in the right TP in first-episode 
patients, failing to find differences in the left side. Investigations of chronic 
schizophrenia patients have also shown inconsistencies. Thus, some studies have  
reported a significant reduction in bilateral TP gray matter volume (Wright et al., 
1999; Gur et al., 2000). On the other hand, in a previous study (Crespo-Facorro et 
al., 2004), we failed to find anymorphological abnormality in the TP in a sample 
ofmales with schizophrenia, although a significant association between TP volume 
and clinical measures was found. Further studies using large samples and 
anatomically defined ROIs are needed to clarify these inconsistencies. We aimed, 
using an ROI approach, (1) to investigate TP gray matter volume and cortical 
surface area anomalies in first-episode schizophrenia patients; (2) to investigate 
whether these morphometric anomalies may significantly influence clinical features 
of the illness.  
 
2. Method  
2.1. Subjects  
Patients were drawn from a large prospective longitudinal study on first-episode 
psychosis (PAFIP) conducted at the University Hospital Marqués de Valdecilla, 
Santander, Spain. It conformed to international standards for research ethics and 
was approved by the local institutional review board. Only those patients (80) with 
a DSMIV diagnosis of schizophrenia 6 months after inclusion entered this study. 
The diagnoses were confirmed using the Structured Clinical Interview for DSM-IV 
(SCID-I) (First et al., 2001). Our operational definition for a “first episode of 
psychosis” included individuals with a non-affective psychotic episode who have  
not received previously antipsychotic treatment regardless of the duration of 
psychosis. Mean age at onset was 29.29 years (S.D.=8.82).  
Forty-eight (60%) of the patients were males. The mean duration of psychosis at 
intake was 17.75 months (S.D.=35.83). At the time of brain magnetic resonance 
imaging (MRI), 14 were taking a conventional antipsychotic (haloperidol) and 66 
patients were on atypical antipsychotics (14 olanzapine, 13 risperidone, 15 
quetiapine, 14 ziprasidone and 10 aripiprazol). Mean time from first antipsychotic 
treatment to scan date was 4.39 weeks (S.D.=3.65). In addition, a sample of 82 
healthy control subjects (52 male subjects, 30 female subjects) was included in this 
study. They were recruited from the community through advertisements. Mean age 
at time of MRI scan was 27.56 years (S.D.=7.62).  
 
2.2. Clinical assessments  
Clinical symptoms were rated using the Brief Psychiatric Rating Scale (BPRS) total 
(Overall and Gorman, 1962), the Scale for the Assessment of Negative Symptoms 
(SANS) (Andreasen, 1983) and the Scale for the Assessment of Positive 
Symptoms (SAPS) (Andreasen, 1984). We also divided psychopathology into three 
dimensions of symptoms (psychotic, negative, and disorganized). Handedness 
was assessed by the Edinburgh Inventory (Oldfield, 1971). Duration of untreated 
illness (DUI) was defined as the time from the first unspecific symptoms related to 
psychosis (for such symptom to be considered, there should be no return to 
previous stable level of functioning) to initiation of adequate antipsychotic drug 
treatment. Duration of untreated psychosis (DUP) was defined as the time from  
the first continuous (present most of the time) psychotic symptom to initiation of 
adequate antipsychotic drug treatment. Duration of prodromal period (DPP) was 
defined as the period from the first unspecific symptoms related to psychosis (as 
defined above) to the first continuous (present most of the time) psychotic 
symptom.  
 
2.3. MRI acquisition and image processing  
Allmulti-modal MRI scans were obtained at the University Hospital of Cantabria 
using a 1.5 Tesla General Electric SIGNA System (GE Medical Systems, 
Milwaukee, WI). Three-dimensional T1-weighted images and two-dimensional PD 
and T2 sequences were acquired. Imaging parameters have been previously 
described (Crespo-Facorro et al., 2007). Images were processed using the 
software BRAINS2 (Andreasen et al., 1996; Magnotta et al., 2002). In short, T1-
weighted images were spatially normalized and resampled to 1.0-mm3 voxels. T2- 
and PDweighted images were aligned to the spatially normalized T1-weighted 
image. In order to classify volumes into gray matter (GM), white matter (WM), and 
cerebrospinal fluid (CSF), the data sets were segmented by using the multispectral 
data and a discriminant analysis method based on automated training class 
selection (Harris et al., 1999). The tissue-classified image was then used to 
generate a triangle-based iso-surface with a threshold of 130 representing pure  
gray matter, which corresponds to the parametric center of the cortex and serves 
as a useful estimate of its physical center (Magnotta et al., 1999). Hand-traced  
ROIs were used to surround contiguous areas of the gray matter triangle iso-
surface.  
 
On each two-dimensional (2D) slice, the cortical surface is visualized as a 
continuous contour that represents the intersection between the 2D plane and the 
threedimensional (3D) triangulated surface. The surface area was measured by 
summing areas of all triangles within the tracings that were made to define the TP.  
The TP was manually outlined without knowledge of the diagnosis using a 
previously published method (Crespo-Facorro et al., 2000; Kim et al., 2000). The 
posterior border of the temporal pole has been defined according to previous 
articles describing the definition of the temporal pole using MRI, and it is defined by 
the coronal plane where there is no frontotemporal junction (Gur et al., 2000; 
Crespo-Facorro et al., 2000; Kim et al., 2000). Since the lateral, medial, anterior,  
superior, and inferior boundaries of the TP are defined by the natural limits of the 
temporal lobe anterior to the frontotemporal junction, tracings are simply done by 
including all triangulated surface lines reflecting the temporal cortex. Moving 
rostrally, tracing is continued until the triangular surface disappears. The reliability 
study for this method was performed on a set of 10 MRI scans by two raters (D.T.  
and C.Q.) using the original tracing from Crespo-Facorro et al. (2000) as gold 
standard. The intra-class r coefficients were r=0.96 for TP gray matter volumes and 
r=0.94 for the TP surface area.  
 
2.4. Statistical analysis  
All statistical analyses were performed with the Statistical Program for the Social 
Sciences (SPSS). To examine differences in ROIs, a repeated measures analysis 
of covariance (ANCOVA) was performed, with side (left or right) as the within-
subjects factor and group (patient, control) and gender as the between-subjects 
factors. For volume measures, the covariates were intracranial volume and age; for 
surface area measures, the covariates were total cortical surface area and age. 
Cohen's d is provided to estimate the magnitude of the differences between 
groups. Similar analyses (excluding gender as between-factor) were conducted for 
both males and females independently. All the outliers (defined as 3 S.D. above or 
below the mean) were excluded from the analyses. Because clinical assessment  
scores were not normally distributed, Spearman's correlation coefficients were 
calculated to examine the relationships between TP gray matter volume and 
clinical variables.  
 
3. Results  
A significant difference between groups was found for age (F=6.79; Pb0.010). 
There were no significant differences between groups with regard to gender, 
laterality, intracranial volume, cortical surface area, parental socioeconomic status, 
alcohol or cannabis use (all PN0.210). These data are available upon request. No 
significant differences were found between patients and control subjects in any of 
the TP measurements (Table 1). There were neither significant group-by-side 
(P'sN0.719) nor group-bygender interactions (P'sN0.191). When males and 
females were analyzed separately, the results remained unchanged (P'sN0.100).  
There were no significant correlations between clinical variables (psychotic, 
negative and disorganized symptom dimensions) and TP gray matter volumes 
(PN0.356; all |r|b0.11).  
 
No significant associations were seen between duration of  
untreated illness, duration of untreated psychosis, duration of prodromal period and 
TP gray matter volumes (PN0.213; all |r|b0.14). Results remained the same when 
IQ was introduced as a covariate.  
 
 
4. Discussion  
In a representative sample of patients with a first-episode of schizophrenia, we 
found that first-episode schizophrenia patients did not show anomalies in TP gray 
matter volume and cortical surface area measurements compared with healthy 
volunteers; TP morphological variables were not associated with clinical variables.  
In first-episode patients, Kasai et al. (2003), using an ROI approach, described a 
reduction in left TP gray matter volume without a gender effect in a sample of 
schizophrenia patients (N=27) who had been minimally treated (median of 1 
month). Witthaus et al. (2009), using voxel-based morphometry, recently reported 
a significant reduction in the right TP, but not in the left side, in a sample of 23 first-
episode schizophrenia patients (17 drug naïve patients). Our results reported  
herein failed to replicate these TP morphological anomalies in firstepisode patients. 
In a previous article we consistently observed no differences in TP morphometry in 
right-handed male chronic schizophrenia patients using the same methodology 
(Crespo-Facorro et al., 2004). Interestingly, when we analyzed the subsample of 
righthanded male first-episode patients, neither did we find significance differences 
between patients and healthy subjects (P'sN0.100). In addition, we failed to 
observed significant differences in the hemispheric asymmetry of TP 
measurements in chronic patients (Crespo-Facorro et al., 2004). In the same way, 
we did not find a significant group×side interaction (which is used to measure  
hemispheric asymmetries) for TP measurements in first-episode patients. 
Investigations reported to date have failed to provide a consistent description of the 
TP anomalies present in schizophrenia. Small sample sizes, lack of 
representativeness of their samples, differences in gender distribution and the 
effect of confounding factors such as alcohol, tobacco and cannabis consumption 
may account for discrepancies between investigations. In addition, differences in 
the methodology (field strength, scanner manufacturer, imaging magnetic 
gradients, software package and version, or the parameters used in the analysis) 
may also account for inconsistencies between studies (Jovicich et al., 2009). The 
clinical implications of TP anomalies in schizophrenia have not been clearly 
established. Our results support the hypothesis that TP gray matter volume is not 
correlated with clinical variables. Similarly, other studies (Gur et al., 2000; Kasai et 
al., 2003) did not find an association between TP volume and clinical measures. 
However, in chronic schizophrenia, there was a significant association between a  
reduction in the TP volume and the severity of disorganized and psychotic 
symptoms (Crespo-Facorro et al., 2004). Further investigations are warranted to 
confirm the functional implications of the TP in the pathophysiology of 
schizophrenia. In summary, our findings, based on a large and representative  
sample of first-episode schizophrenia patients, do not confirm the presence of 
significant TP morphometric anomalies. Neither did we observe associations 
between TP gray matter volume and clinical measures.  
 
